3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Peripheral Nervous System Diseases
2
Urinary Bladder Neoplasms
1
Signs and Symptoms
1
Sepsis
1
Sarcoma
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Menstruation Disturbances
1
Febrile Neutropenia
1
Cross Infection
1
Colorectal Neoplasms
1
Interventions
pasireotide
1
lutetium Lu 177 dotatate
1
lanreotide
1
amino-acid, glucose, and electrolyte solution
1
Sunitinib
1
Octreotide
1
Everolimus
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastro-enteropancreatic neuroendocrine tumor
×
Acupuncture Therapy
×
90 days
×
Clear all
No trials found.